Purchase Order 75N91024P00243
Award Date
2/19/24
Potential Completion Date
2/18/25
Potential Value
$24K
Federal Agency
National Cancer Institute
Awardee
Novogene Corporation Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sacramento, CA 95826, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order totaling $24,864 by the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health. The contract calls for Novogene to provide laboratory testing services in Bethesda, Maryland, in support of the agency's biomedical research efforts. As a previous provider of genomic sequencing and bioinformatics services under over 100 federal...
Novogene Corp Inc., a minority-owned small business, has been awarded a $13,982 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide RNA sequencing services in Bethesda, Maryland. The sequencing will support the agency's biomedical research efforts. As a prime contractor supporting multiple federal agencies, Novogene has over 100 contracts to conduct genomic sequencing and analysis for studies into diseases,...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...
This federal contract award is for $143,850.00 to Novogene Corp Inc., a minority-owned small business, by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse. The contract is a firm fixed price purchase order for genomic sequencing and bioinformatics services to support biomedical research. Novogene has previously received over 100 prime contracts from federal agencies including the NIH, Department of Veterans Affairs, Department of...
This is a $13,400 firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health, to Novogene Corp Inc., a minority-owned small business. The contract is for cell handling and sequencing services, with a period of performance through September 30, 2024. Novogene is a genomics services provider that specializes in next-generation DNA and RNA sequencing, bioinformatics, and research support for federal agencies across...
This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $10,880 contract has a completion date of December 11, 2024 and was not set aside. Novogene is a provider of genomic sequencing and bioinformatics services, supporting various federal agencies' biomedical, agricultural, environmental, and basic research efforts. This award...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $219,720.00 firm fixed price purchase order to Novogene Corp Inc., a minority-owned small business, to conduct RNA sequencing and bioinformatics analysis. The work supports research into identifying biomarker signatures of radiation exposure and organ-specific radiation injury using samples from a non-human primate model and human organ-on-a-chip system. The contract requires a...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The $11,766 contract is for sequencing and analysis services to be provided by Novogene Corp Inc., a minority-owned small business. The services include next-generation sequencing of DNA and RNA samples, library preparation, and associated bioinformatics analysis. This contract is not designated as...
This is a firm fixed-price purchase order awarded by the Plains Area division of a civilian federal agency to Novogene Corporation Inc., a minority-owned small business. The contract, valued at $62,346.90, is for genomic sequencing services and covers the period through December 31, 2024. Novogene is a provider of next-generation sequencing technologies, including whole genome, exome, transcriptome, and metagenomic sequencing, and has delivered these services to various government agencies...